<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04783961</url>
  </required_header>
  <id_info>
    <org_study_id>2248</org_study_id>
    <nct_id>NCT04783961</nct_id>
  </id_info>
  <brief_title>Cold Snare Endoscopic Resection for Duodenal Adenomas</brief_title>
  <acronym>COLD SNARE</acronym>
  <official_title>Cold Snare Endoscopic Resection for Duodenal Adenomas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Clinico Humanitas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto Clinico Humanitas</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Non-ampullary sporadic duodenal adenomas (SDA) are rare lesions, incidentally discovered in&#xD;
      up to only 5% of patients during routine endoscopy. In any case, these lesions require&#xD;
      treatment due to their potential malignant transformation because of the adenoma-carcinoma&#xD;
      sequence, occurring in 30-85% of cases. Endoscopic resection (ER) of SDA represents an&#xD;
      attractive alternative to surgical resection in appropriately selected patients, with lower&#xD;
      morbidity and mortality rates.&#xD;
&#xD;
      However, most endoscopists are not keen to resect larger lesions due to the risk of&#xD;
      complications. Indeed, endoscopic resection in the duodenum has unique challenges: thin wall,&#xD;
      high vascularity, very limited space and harmful effects of bile and acid both acting on the&#xD;
      ER defect.&#xD;
&#xD;
      Cold snare endoscopic resection has been shown to be a viable method for removing colorectal&#xD;
      lesions with comparable efficacy outcomes compared to conventional polypectomy/endoscopic&#xD;
      mucosal resection (EMR) and a promising safety profile. As a matter of fact, adverse events&#xD;
      associated with hot snare resection technique such as delayed bleeding, post-polypectomy&#xD;
      syndrome, and perforation are all related to electrocautery-induced injury.&#xD;
&#xD;
      Performing cold snare piece-meal resection and avoiding the need of thermal therapy, may have&#xD;
      a major impact in the duodenum where the risk of delayed bleeding and perforation is&#xD;
      consistent.&#xD;
&#xD;
      The aim of this pilot study is to prospectively evaluate the feasibility and the efficacy in&#xD;
      term of safety and efficacy of cold snare endoscopic resection.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2021</start_date>
  <completion_date type="Anticipated">March 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patints that will have serious and non-serious adverse events</measure>
    <time_frame>3 Months</time_frame>
    <description>endoscopic appearance&#xD;
scar biopsies&#xD;
perforation risk</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of residual adenomas</measure>
    <time_frame>3 Months</time_frame>
    <description>endoscopic appearance&#xD;
scar biopsies</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of endoscopic procedure</measure>
    <time_frame>3 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>3 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital readmission</measure>
    <time_frame>3 Months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Duodenal Adenomas</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cold snare endoscopic resection</intervention_name>
    <description>Cold snare endoscopic resection</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with diagnosed large duodenal adenomas (&gt;20 mm)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        â€¢ Patients able to give informed consent to involvement in trial.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient's with known strictures/stenosis&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Patients who did not consent to study&#xD;
&#xD;
          -  Bleeding diathesis&#xD;
&#xD;
          -  Anticoagulants&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alessandro Repici, MD</last_name>
    <phone>0039-02-82247493</phone>
    <email>alessandro.repici@hunimed.eu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Roberta Maselli, MD</last_name>
    <phone>0039-02-82247570</phone>
    <email>roberta.maselli@humanitas.it</email>
  </overall_contact_backup>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 2, 2021</study_first_submitted>
  <study_first_submitted_qc>March 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2021</study_first_posted>
  <last_update_submitted>March 4, 2021</last_update_submitted>
  <last_update_submitted_qc>March 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

